With a 20% increase in growth portfolio revenue and strategic cost savings, Bristol-Myers Squibb Co (BMY) raises its ...

Autolus has picked up its first product approval, getting an FDA green light for Aucatzyl as a treatment for patients with ...

Bristol-Myers Squibb (NYSE:BMY), a global biopharmaceutical company, finds itself at a critical juncture as it navigates a complex landscape of opportunities and challenges. The company, known for its ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other pharma ...

She’s been with Bristol Myers Squibb for more than 20 years, holding several senior positions in the UK and globally across different therapy areas. With her impressive track record as a collaborative ...

Owkin has enticed another big pharma partner with its artificial intelligence-powered clinical development platform, Bristol-Myers Squibb ... AI specialist – UK-based Exscientia – in a ...

Application error: a client-side exception has occurred (see the browser console for more information).

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...

Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is ...